These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21191437)

  • 1. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history.
    Dalal AA; Demuro-Mercon C; Lewis S; Nelson L; Gilligan T; McLeod L
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 5():425-34. PubMed ID: 21191437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of airway obstruction assessed by lung function questionnaire.
    Mintz ML; Yawn BP; Mannino DM; Donohue JF; Hanania NA; Grellet CA; Gilsenan AW; McLeod LD; Dalal AA; Raphiou IH; Prillaman BA; Crater GD; Cicale MJ; Mapel DW
    Mayo Clin Proc; 2011 May; 86(5):375-81. PubMed ID: 21531880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).
    Hanania NA; Mannino DM; Yawn BP; Mapel DW; Martinez FJ; Donohue JF; Kosinski M; Rendas-Baum R; Mintz M; Samuels S; Jhingran P; Dalal AA
    Respir Med; 2010 Aug; 104(8):1160-70. PubMed ID: 20226647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.
    Yawn BP; Mapel DW; Mannino DM; Martinez FJ; Donohue JF; Hanania NA; Kosinski M; Rendas-Baum R; Mintz M; Samuels S; Dalal AA;
    Int J Chron Obstruct Pulmon Dis; 2010 Feb; 5():1-10. PubMed ID: 20368906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D; Nakano Y; Onishi K; Hagan G; Jones P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1357-63. PubMed ID: 25525353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
    Siddharthan T; Pollard SL; Quaderi SA; Rykiel NA; Wosu AC; Alupo P; Barber JA; Cárdenas MK; Chandyo RK; Flores-Flores O; Kirenga B; Miranda JJ; Mohan S; Ricciardi F; Sharma AK; Das SK; Shrestha L; Soares MO; Checkley W; Hurst JR;
    JAMA; 2022 Jan; 327(2):151-160. PubMed ID: 35015039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Six Chronic Obstructive Pulmonary Disease Screening Questionnaires in the Chinese Population.
    Zhou J; Yu N; Li X; Wang W
    Int J Chron Obstruct Pulmon Dis; 2022; 17():317-327. PubMed ID: 35177900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating patient-reported outcome measurement comparability between paper and alternate versions, using the lung function questionnaire as an example.
    Dalal AA; Nelson L; Gilligan T; McLeod L; Lewis S; DeMuro-Mercon C
    Value Health; 2011; 14(5):712-20. PubMed ID: 21839410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history.
    Campo G; Pavasini R; Barbetta C; Maietti E; Mascetti S; Biscaglia S; Zaraket F; Spitaleri G; Gallo F; Tonet E; Papi A; Ferrari R; Contoli M
    Int J Cardiol; 2016 Nov; 222():806-812. PubMed ID: 27522379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.
    Samukawa T; Matsumoto K; Tsukuya G; Koriyama C; Fukuyama S; Uchida A; Mizuno K; Miyahara H; Kiyohara Y; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1469-1481. PubMed ID: 28553099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care.
    Spyratos D; Haidich AB; Chloros D; Michalopoulou D; Sichletidis L
    Respiration; 2017; 93(2):83-89. PubMed ID: 28052294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G; Samukawa T; Matsumoto K; Fukuyama S; Kumamoto T; Uchida A; Koriyama C; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirometric testing on World COPD Day.
    Grzetic-Romcevic T; Devcic B; Sonc S
    Int J Chron Obstruct Pulmon Dis; 2011; 6():141-6. PubMed ID: 21468166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD.
    Moretz C; Annavarapu S; Luthra R; Goldfarb S; Renda A; Shaikh A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2019; 14():439-446. PubMed ID: 30863044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VitalQPlus: a potential screening tool for early diagnosis of COPD.
    Sui CF; Ming LC; Neoh CF; Ibrahim B
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1613-22. PubMed ID: 26316735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.